Welcome to LookChem.com Sign In|Join Free

CAS

  • or

951174-11-1

Post Buying Request

951174-11-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

951174-11-1 Usage

General Description

Tert-Butyl 4-(5-methoxy-1H-indol-3-yl)-1-piperidinecarboxylate is a chemical compound that belongs to the class of piperidinecarboxylate derivatives. It is a synthetic compound with a molecular formula C20H31NO3 and a molecular weight of 333.47 g/mol. This chemical is commonly used in organic synthesis and pharmaceutical research as a building block for the preparation of various indole-based compounds. The tert-butyl group at the 4th position of the piperidinecarboxylate moiety provides stability and sterical hindrance, while the 5-methoxy-1H-indol-3-yl group adds biological activity to the molecule. Tert-butyl 4-(5-methoxy-1H-indol-3-yl)-1-piperidinecarboxylate is of interest in medicinal chemistry for its potential pharmacological properties and therapeutic applications.

Check Digit Verification of cas no

The CAS Registry Mumber 951174-11-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,1,7 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 951174-11:
(8*9)+(7*5)+(6*1)+(5*1)+(4*7)+(3*4)+(2*1)+(1*1)=161
161 % 10 = 1
So 951174-11-1 is a valid CAS Registry Number.
InChI:InChI=1/C19H26N2O3/c1-19(2,3)24-18(22)21-9-7-13(8-10-21)16-12-20-17-6-5-14(23-4)11-15(16)17/h5-6,11-13,20H,7-10H2,1-4H3

951174-11-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-(5-methoxy-1H-indol-3-yl)piperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names TERT-BUTYL 4-(5-METHOXY-1H-INDOL-3-YL)-1-PIPERIDINECARBOXYLATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:951174-11-1 SDS

951174-11-1Downstream Products

951174-11-1Relevant articles and documents

N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties

Zajdel, Pawe?,Marciniec, Krzysztof,Sata?a, Grzegorz,Canale, Vittorio,Kos, Tomasz,Partyka, Anna,Jastrz?bska-Wi?sek, Magdalena,Weso?owska, Anna,Basińska-Ziobroń, Agnieszka,Wójcikowski, Jacek,Daniel, W?adys?awa A.,Bojarski, Andrzej J.,Popik, Piotr

, p. 618 - 622 (2016/07/06)

A series of N1-azinylsulfonyl-3-(1,2,3,6,tetrahyrdopyridin-4-yl)-1H-indole derivatives was designed to obtain highly potent 5-HT6 receptor ligands. The study allowed for the identification of 25 (4-{[5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-1-yl]sulfonyl}isoquinoline), a potent and selective 5-HT6 receptor antagonist. The selected compound, was evaluated in vivo in a novel object recognition (NOR) and forced swim (FST) tests in rats, demonstrating distinct pro-cognitive and antidepressant-like properties (MED = 1 mg/kg and 0.1 mg/kg, i.p., respectively). Compound SB-742457, used as comparator, reversed memory deficits in NOR task in similar doses, while in FST it was active in 10-30-fold higher dose (3 mg/kg). In contrast to SB-742457, which was active in Vogel test (MED = 3 mg/kg), compound 25 displayed no anxiolytic activity.

Substituted heterocyclic compounds and its application on the medicament (by machine translation)

-

Paragraph 0196; 0197; 0198; 0199; 0219; 0220; 0221; 0222, (2017/06/02)

The invention relates to substituted heterocyclic compounds and its application on the medicament, in particular to a novel class of substituted heterocyclic compounds or its isomer, tautomer, nitrogen oxide, hydrate, solvate, metabolite, pharmaceutically acceptable salt or prodrug, and their method of preparation. The invention also relates to the compounds of the invention pharmaceutical composition, and said compound or pharmaceutical compositions for the treatment5-HT6receptor-related diseases, in particular Alzheimer's disease in the use thereof. (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 951174-11-1